Article · 8 Apr 2026
ArticlePublished 10 Nov 2022
Quantification and molecular characterization of extended spectrum betalactamase producing enterobacteriaceae from agrop
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Bacterial infections are the commonest in both community and healthcare settings. Emergency of Extended Spectrum Beta-Lactamase producing Enterobacteriaceae has contributed to poor clinical outcomes. More efforts regarding antibiotic resistance have been dedicated to clinical settings and we do not know the extent of the catastrophe in community settings. We aimed at determining the burden, antimicrobial susceptibility patterns and molecular characteristics of Extended Spectrum Beta-Lactamase producing Enterobacteriaceae in agro-pastoral communities of Mbarara district, South Western Uganda. Methods: A laboratory based descriptive cross-sectional study was carried out among Enterobacteriaceae isolated from outpatients presenting with signs and symptoms of Urinary Tract Infections. Urine samples were delivered to Microbiology Laboratory of Mbarara University of Science and Technology for culture, identification, testing for ESBL production and Antibiotic Susceptibility Testing. Molecular characterization of ESBL producing Enterobacteriaceae was carried out at Medical and Molecular Laboratories Limited of Makerere University. Results: A total of 88 Enterobacteriaceae fulfilling the inclusion criteria were considered into the study. Escherichia coli 70.45% and Klebsiella pneumoniae 13.64% were the most isolated followed by Klebsiella oxytoca, Proteus mirabilis and Enterobacter aerogenes at 10.23%, 3.41% and 2.27% respectively. The production of ESBL was observed at 23.86%. Generally, high resistance rates were observed against Ampicillin 100%, Cefepime 100%, Aztreonam 95.24%, Nalidixic acid 90.48%, Ciprofloxacin 85.71% and Amoxicillin/clavulanate 80.95%. High rates of sensitivity were observed to Meropenem 95.24%, Imipenem 95.24%, Amikacin 95.24%, Gentamycin 90.48%, Cefoxitin 76.19% Piperacillin/tazobactam 80.95% and Nitrofurantoin 66. 67%. Multi-Drug Resistance (MDR) was observed at 85.71%. The most prevalent genes in ESBL producing Enterobacteriaceae were CTX-MU (Cefotaxime-Munich) 46.7%, TEM 30.00% and SHV (Sulfhydryl Reagent Variable) 23.3%. Conclusion: We demonstrated high prevalence, antibiotic resistance rates among Extended Spectrum Beta-Lactamase producing Enterobacteriaceae in the community. We recommend more community ESBL related studies and a One Health Approach to guide public health interventions.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Systematic Reviews in Pharmacy.
Article · 30 Sep 2025
AI?IoT Integration: Balancing Innovation and Compliance in Pharmaceutical Manufacturing
Article · 18 Aug 2025
Investigation of microbiological and organoleptic properties of bee products (bee venom, solid pollen, and royal jelly) through water activity quantification during 8 days of storage
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSystematic Reviews in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ivan Muhwezi”
- BylineArticles whose byline prints “Joel Bazira”
- BylineArticles whose byline prints “Henry Zamarano”
- BylineArticles whose byline prints “Frederick Byarugaba”
- BylineArticles whose byline prints “Wilber Sabiiti”
- BylineArticles whose byline prints “Mathew Holden”
- BylineArticles whose byline prints “Benon B Asiimwe”